Tariq Sethi
Chief Tech/Sci/R&D Officer bij ONCIMMUNE HOLDINGS PLC
Actieve functies van Tariq Sethi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01-10-2019 | - |
Loopbaan van Tariq Sethi
Eerdere bekende functies van Tariq Sethi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GALECTO, INC. | Founder | 01-01-2011 | - |
| The University of Edinburgh | Corporate Officer/Principal | - | - |
King's Health Partners Ltd.
 King's Health Partners Ltd. Miscellaneous Commercial ServicesCommercial Services King's Health Partners Ltd. operates as an academic health sciences center. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
| King's College London | Corporate Officer/Principal | - | - |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Founder | 01-01-2011 | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
| Denemarken | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| GALECTO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
King's Health Partners Ltd.
King's Health Partners Ltd. Miscellaneous Commercial ServicesCommercial Services King's Health Partners Ltd. operates as an academic health sciences center. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- Tariq Sethi
- Ervaring
